Acta Pharmacologica Sinica (2009) 30: 175-183; doi: 10.1038/aps.2008.30; published online 26th January 2009

 
Original Article
[ Full text ]
 
Proteomic analysis of the effect of iptakalim on human pulmonary arterial smooth muscle cell proliferation
 

Ming-xia YANG1,2, Zheng-xia LIU2, Shu ZHANG4, Yu JING1, Shi-jiang ZHANG3, Wei-ping XIE1, Lei MA2, Chang-liang ZHU2, Hong WANG1,*

1Department of Respiratory Medicine, The First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China; 2Department of Pathogen Biology, Nanjing Medical University, Nanjing 210029, China; 3Department of Cardiothoracic Surgery, The First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China; 4The Clinical Experiment Center, The First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China

 

Aim: To investigate the anti-proliferative effect of iptakalim (Ipt), a newly selective KATP channel opener, in endothelin-1 (ET-1)-induced human pulmonary arterial smooth muscle cells (PASMCs) using proteomic analysis.

Methods: Human PASMCs were incubated with ET-1 (10-8 mol/L) and ET-1 (10-8 mol/L) plus iptaklim (10-5 mol/L) for 24 h. Analysis via 2-DE gel electrophoresis and MALDI-TOF-MS was employed to display the different protein profiles of whole-cell protein from cultures of control, ET-1 treatment alone, and treatment with ET-1 and iptaklim combined. Real time RT-PCR and Western blot analysis were used to confirm the proteomic analysis.

Results: When iptakalim inhibited the proliferative effect of ET-1 in human PASMCs by opening the KATP channels, the expression of different groups of cellular proteins was changed, including cytoskeleton-associated proteins, plasma membrane proteins and receptors, chaperone proteins, ion transport–associated proteins, and glycolytic and metabolism-associated proteins. We found that iptakalim could inhibit the proliferation of human PASMCs partly by affecting the expression of Hsp60, vimentin, nucleoporin P54 (NUP54) and Bcl-XL by opening the KATP channel.

Conclusion: The data suggest that a wide range of signaling pathways may be involved in abolishing ET-1-induced proliferation of human PASMCs following iptakalim treatment.

 

Keywords: pulmonary arterial smooth muscle cells; KATP channel opener; iptakalim; proteomics; proliferation

 

This work was supported by the Jiangsu Commission of Science and Technology (Hong WANG) under contract No BJ200608, the National Natural Science Foundation of China (Hong WANG) under contract No 30871139 and by a research fund from the Natural Science Foundation of Jiangsu Province (Wei-ping XIE) under contract No BK2006246.

* Correspondence to Prof Hong WANG.
E-mail hongwang_njmu@yahoo.com.cn
Received 2008-09-28 Accepted 2008-12-23

[ Full text ]
 

Copyright©APS 2009
Add: 294 Tai-Yuan Road, Shanghai 200031, China
Phn: 86-21-5492-2821 Fax: 86-21-5492-2823
E-mail: aps@mail.shcnc.ac.cn